Centene Corp Files 8-K for Regulation FD Disclosure

Ticker: CNC · Form: 8-K · Filed: 2025-09-11T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, regulation-fd

TL;DR

Centene filed an 8-K for a Reg FD disclosure on Sept 11, event on Sept 10.

AI Summary

Centene Corporation filed an 8-K on September 11, 2025, reporting an event that occurred on September 10, 2025. The filing is related to a Regulation FD Disclosure. Centene Corporation is incorporated in Delaware and headquartered in St. Louis, Missouri.

Why It Matters

This filing indicates Centene Corporation is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.

Risk Assessment

Risk Level: low — This is a standard regulatory filing and does not appear to contain any immediate financial or operational risks.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The filing does not specify the exact nature of the Regulation FD disclosure, only that it is being made.

When was the event that triggered this 8-K filing?

The earliest event reported occurred on September 10, 2025.

What is Centene Corporation's primary business sector?

Centene Corporation is in the HOSPITAL & MEDICAL SERVICE PLANS sector, SIC code 6324.

Where is Centene Corporation's principal executive office located?

The principal executive offices are located at 7700 Forsyth Boulevard, St. Louis, Missouri 63105.

Is this filing related to any specific SEC Act?

Yes, this filing is made pursuant to the 1934 Act.

From the Filing

0001071739-25-000168.txt : 20250911 0001071739-25-000168.hdr.sgml : 20250911 20250910214056 ACCESSION NUMBER: 0001071739-25-000168 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250911 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250911 DATE AS OF CHANGE: 20250910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 251307098 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20250911.htm 8-K cnc-20250911 0001071739 false 0001071739 2025-09-11 2025-09-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 7.01 REGULATION FD DISCLOSURE Centene Corporation (the Company) will be participating at the Deutsche Bank 2025 Healthcare Summit on Thursday, September 11, 2025, at 8:00 a.m. EDT. Members of management will discuss the Company’s business and financial results through August, which are consistent with its previously-issued full year 2025 forecast of approximately $1.75 adjusted diluted earnings per share (EPS). A simultaneous live audio webcast of Centene's participation in the summit on September 11 will be available at https://event.webcasts.com/starthere.jsp?ei=1734400&tp_key=905baa0793&tp_special=8. A webcast replay will be available following the presentation via the Company's website at www.centene.com, under the Investors section. Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures in this Form

View on Read The Filing